<VariationArchive VariationID="2066828" VariationName="NM_018941.4(CLN8):c.474_477dup (p.Ala160fs)" VariationType="Duplication" Accession="VCV002066828" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2122090" VariationID="2066828">
      <GeneList>
        <Gene Symbol="CLN8" FullName="CLN8 transmembrane ER and ERGIC protein" GeneID="2055" HGNC_ID="HGNC:2079" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="1753059" stop="1786570" display_start="1753059" display_stop="1786570" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NT_187680.1" start="165717" stop="199228" display_start="165717" display_stop="199228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="1711869" stop="1734735" display_start="1711869" display_stop="1734735" Strand="+" />
          </Location>
          <OMIM>607837</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018941.4(CLN8):c.474_477dup (p.Ala160fs)</Name>
      <CanonicalSPDI>NC_000008.11:1771524:CTATCTA:CTATCTATCTA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="1771524" stop="1771525" display_start="1771524" display_stop="1771525" variantLength="4" positionVCF="1771524" referenceAlleleVCF="A" alternateAlleleVCF="ACTAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="1719690" stop="1719691" display_start="1719690" display_stop="1719691" variantLength="4" positionVCF="1719690" referenceAlleleVCF="A" alternateAlleleVCF="ACTAT" />
      </Location>
      <ProteinChange>A160fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.1719694_1719697dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.1719694_1719697dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.1771528_1771531dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.1771528_1771531dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008656.2" sequenceAccession="NG_008656" sequenceVersion="2" change="g.20751_20754dup">
            <Expression>NG_008656.2:g.20751_20754dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018941.4" sequenceAccession="NM_018941" sequenceVersion="4" change="c.474_477dup" MANESelect="true">
            <Expression>NM_018941.4:c.474_477dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061764.2" sequenceAccession="NP_061764" sequenceVersion="2" change="p.Ala160fs">
            <Expression>NP_061764.2:p.Ala160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_691" sequenceAccession="LRG_691">
            <Expression>LRG_691:g.20751_20754dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_691t1" sequenceAccession="LRG_691t1">
            <Expression>LRG_691t1:c.474_477dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_691p1" sequenceAccession="LRG_691p1" change="p.Ala160Serfs">
            <Expression>LRG_691p1:p.Ala160Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018941.4(CLN8):c.474_477dup (p.Ala160fs) AND Neuronal ceroid lipofuscinosis" Accession="RCV002943581" Version="2">
        <ClassifiedConditionList TraitSetID="8888">
          <ClassifiedCondition DB="MedGen" ID="C0027877">Neuronal ceroid lipofuscinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1409" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis</ElementValue>
                <XRef ID="Neuronal+Ceroid+Lipofuscinosis/5192" DB="Genetic Alliance" />
                <XRef ID="MONDO:0016295" DB="MONDO" />
                <XRef ID="42012007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceroid storage disease</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000509415" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500216" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509416" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509800" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10739" />
                <XRef ID="10739" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">19084560</ID>
              </Citation>
              <XRef ID="216" DB="Orphanet" />
              <XRef ID="79263" DB="Orphanet" />
              <XRef ID="C0027877" DB="MedGen" />
              <XRef ID="MONDO:0016295" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5967735" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15546126|MedGen:C0027877" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003277654" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CLN8 protein in which other variant(s) (p.Val236Serfs*8) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with CLN8-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala160Serfs*88) in the CLN8 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 127 amino acid(s) of the CLN8 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.1719690_1719691insCTAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027877" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5967735" TraitType="Disease" MappingType="XRef" MappingValue="C0027877" MappingRef="MedGen">
        <MedGen CUI="C0027877" Name="Neuronal ceroid lipofuscinosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

